REGENERON PHARMACEUTICALS, INC.: revenue
| Value | {"amount": 238457000, "concept": "us-gaap:Revenues", "currency": "USD"} |
|---|---|
| Period | 2008-01-01 – 2008-12-31 |
| Status | current |
| Entity | REGENERON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-09-01T12:57:22.486063+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/438bf687-85db-4b86-9b3d-86cd12466496
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001206774-11-000263Retrieved: 2026-09-01T12:57:22.486063+02:00
Raw response sha256:
8ac8537cd8b5e571e7f527aae3e223c6…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000872589/revenue/2008-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/438bf687-85db-4b86-9b3d-86cd12466496
History
- supersedes {"amount": 6249000, "concept": "us-gaap:SalesRevenueGoodsNet", "currency": "USD"} (evidence 0001206774-11-000263)